#Efficacy

John Warner

biblioracle

When I sat down to consider writing what would become Why They Can't Write, I thought it would be a book of pedagogy, an articulation of a particular philosophy towards

The Pathfinder

path1finder

Thread about $XENE Xenon Pharmceuticals‘ main asset XEN1101: XEN1101 is a – presumably – much improved version of an older approved drug: ezogabine (= retigabine; trade names EU/USA Trobalt/Potiga). This

Mac n’ Chise 🧬🧫🦠

sailorrooscout

Undoubtedly there is going to be a lot of conversation surrounding the new viral variants. This is me being completely transparent when I say this: please don’t panic. The most

Maciek Boni

maciekboni

Hi #epitwitter short summary here on @athutran's results on optimal vaccine allocation using real-time seroprevalence estimates, for MA and RI (abt 25% to 30% seroprev on Jan 1). Results exactly

Matthew Herder

cmrherder

Having predicted that the PM was about to announce the authorization of one or more Covid vaccines yesterday, I was actually a little relieved when the substance of the announcement

Dr. Angela Rasmussen

angie_rasmussen

Big news today about another vaccine candidate. Take home messages:-It's safe-It's immunogenic (neutralizing antibodies and antigen-specific T cells)-It's a good size (n=1077 patients, 543 of whom got the vaccine vs

Alasdair Munro

apsmunro

This potentially incredibly good newsTwitter is about to be full of articles about "herd immunity" again, but now with words laced in honey rather than shouting and hissingSome things we

Pras Francis, MD PhD

PrasFrancis

Covid-19 was discovered/named in December, 2019. By November, 2020, we have preliminary data from Phase III clinical trials for two vaccines. The previous record for vaccine development was 4 years.

FOOP Organic Biosciences

FOOPOrganic

Microbes & Bioavailibility: Getting the most out of your Garden | Thread #My420Cents #FOOP 1/ Microbes are microorganisms that make up all aspects of life around us. The microbes in

Kai Kupferschmidt

kakape

More vaccine news, this time from phase 3 trial of Johnson&Johnson:According to the company, their vaccine based on an adenovirus was 66% effective at preventing moderate and severe #covid19, 28

Liz Szabo

LizSzabo

LIVE: Operation Warp Speed's Moncel Slaoui said @modernatx vaccine has efficacy of 94.1% overall, 87% efficacy in preventing moderate disease in adults over 65, 100% effective at preventing severe disease

The Economist

TheEconomist

The first fully-tested covid-19 vaccine has been authorised for use in Britain. How did the country's regulator approve the Pfizer-BioNTech jab so quickly? A bumper thread (1/10) https://econ.st/36v2q3l Britain's

Danny Boy

Care2much18

Hundreds of American tourists have little-to-no power to cause outbreaks. Clusters, sure, but outbreaks are on society.Italy were the first to ban flights from China and that ended in dismal

Mac n’ Chise 🧬🧫🦠

sailorrooscout

Let’s talk about immunity and why it’s important to take certain factors into consideration when we look at these studies and maybe why the most recent one on AstraZeneca’s effectiveness

Jess Scott

cardiac_fitness

Performance status in cancer isn’t broken, but is it time for an upgrade? Check out our commentary with @ElisabethEdvar2 Guro Stene and Lee Jones in @ASCO_pubs on different tools to

Alexander Gaffney

AlecGaffney

So I guess while we're all waiting around for FDA's vaccine authorization notice, a few things that I'll be looking for in the notice:- Which populations are covered under the

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.